Abiopharma

🔍 Tawakol Omar (Director)

Company: Trade Desk, Inc. (TTD)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Acquired 12,220 shares of Class A Common Stock (Direct)
  Date: 2026-05-04 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,038.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: Grant of restricted stock units under the Issuer's 2025 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of Issuer's Class A common stock.
• F2: The restricted stock units vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested units shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
• F3: The restricted stock units were issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant.